This research project will be performed among forensic outpatients with a proven lack of anger management skills
Conditions
Interventions
In our study, real-time biofeedback will be added to regular aggression regulation treatment for two weeks (during the intervention phase).
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Proven lack of anger management skills, indicated by either a recently committed violent crime and/or a high risk of committing one; 2. Assigned to individual outpatient Aggression Regulation Treatment after multidisciplinary consultation; 3. Basic understanding of mobile applications; 4. Aged 16 years or above.
Exclusion criteria
Exclusion criteria: 1. Acute manic or psychotic symptoms according to the clinician and/or DSM-V criteria as measured with the (revised) Mini International Neuropsychiatric Interview (MINI), indicated by a score of 3 (or higher) on item 6 or addendum item 1 of the Health of the Nations Outcome Scales (HoNOS); 2. Current high risk of suicide requiring immediate intervention according to the clinician and/or DSM-V criteria as measured with the MINI, indicated by a score of 3 (or higher) on item 2 of the HoNOS; 3. Severe addiction problems, indicated by a score of 4 on the HoNOS, or severe conditions requiring immediate intervention or hospitalisation; 4. Insufficient understanding of the spoken and written Dutch language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychophysiological awareness and aggression-related concepts during the ABA-design (baseline, intervention, and follow-up phase using Ecological Momentary Assesment) and at T1 by use of the Agression Questionnaire (AQ) and Anger Bodily Sensations Questionnaire (ABSQ). Also, physiological measures (heart rate) are measured during the ABA-design (baseline, intervention and follow-up). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary measures, such as anger and aggression (e.g. STAXI-2), emotion regulation (DERS), psychiatric functioning (HoNOS), will be assessed before and after the four-week ABA-period (T1); and some also at 1 month follow-up (Tf). Also, the system usability of the biofeedback will be evaluated at T1, both quantitatively and qualitatively. At T0, several other outcomes will be assessed to describe the sample, such as aggression type (RPQ), psychopathy (YPI-s) and demographic information. | — |
Contacts
Public ContactAnnemieke ter Harmsel
Inforsa / Arkin
Outcome results
None listed